# Sonography for COVID-19 Vaccines Related Reactive Lymphadenopathy

> **NCT06429020** · — · COMPLETED · sponsor: **Chimei Medical Center** · enrollment: 1089 (actual)

## Conditions studied

- Reactive Axillary Lymphadenopathy for SARS-CoV-2 Vaccines in the Asian Taiwanese Population

## Interventions

- **BIOLOGICAL:** the AstraZeneca ChAdOx1 (AZ) vaccine, Moderna mRNA-1273 (Moderna) vaccine, and Pfizer-BioNTech BNT162b2 (BNT) vaccine.

## Key facts

- **NCT ID:** NCT06429020
- **Lead sponsor:** Chimei Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 1089 (ACTUAL)
- **Last updated:** 2024-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06429020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06429020, "Sonography for COVID-19 Vaccines Related Reactive Lymphadenopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06429020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*